债券代码：113660 债券简称：寿 22 转债 浙江寿仙谷医药股份有限公司 关于"寿 22 转债"转股结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 经中国证券监督管理委员会"证监许可20222165 号"文核准，公司于 2022 年 11 月 17 日公开发行 398 万张可转换公司债券，每张面值 100 元，发行总额 第三年为 1%、第四年为 1.5%、第五年为 2%、第六年为 2.5%。 经上海证券交易所自律监管决定书2022332 号文同意，公司 39,800.00 万元 可转换公司债券于 2022 年 12 月 12 日起在上交所挂牌交易，债券简称"寿 22 转债"，债券代码"113660"。 证券代码：603896 证券简称：寿仙谷 公告编号：2025-047 （公告 编号：2023-039）、《寿仙谷关于权益分派引起的"寿 22 转债"转股价格调整的 公告》（公告编号：2024-030、2025-041）、《寿仙谷关于回购专用证券账户股份 注销完成暨调整可转债转股价格暨转股 ...

Core Viewpoint - Zhejiang Shouxiangu Pharmaceutical Co., Ltd. maintains its credit rating of "AA-" for both its corporate and convertible bonds, with a stable outlook as per the latest tracking report by Zhongzheng Pengyuan [1][2]. Group 1: Credit Rating Details - The previous credit rating for the company and its convertible bonds was "AA-", with a stable outlook, issued on June 25, 2024 [1][2]. - The latest tracking credit rating report was issued on June 20, 2025, confirming the ratings remain unchanged [2]. Group 2: Regulatory Compliance - The company conducted the credit rating in accordance with the "Measures for the Issuance and Trading of Corporate Bonds" and the "Listing Rules for Corporate Bonds on the Shanghai Stock Exchange" [1].

Core Points - Zhejiang Shuxian Valley Pharmaceutical Co., Ltd. announced a cash dividend of 0.27 yuan per share for the fiscal year 2024, approved at the annual shareholders' meeting on May 13, 2025 [2][3][4] - The total cash dividend distribution amounts to approximately 53.53 million yuan, based on a total share capital of 198,243,911 shares [4] - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the record date [3][4] Distribution Plan - The cash dividend distribution is based on the company's total share capital as of the record date, with each share receiving a cash dividend of 0.27 yuan (before tax) [4] - The distribution will be managed by the China Securities Depository and Clearing Corporation, with shareholders who have completed designated transactions able to receive their dividends on the payment date [6][8] Taxation Details - For individual shareholders holding unrestricted shares, no income tax will be withheld at the time of dividend distribution; tax will be calculated based on the holding period when shares are sold [9] - For shares held for less than one month, the tax rate is 20%; for one month to one year, the tax rate is 10%; and for over one year, dividends are exempt from personal income tax [9] - For foreign institutional investors, a 10% withholding tax will apply, resulting in a net dividend of 0.243 yuan per share [10] Convertible Bond Adjustment - The company announced an adjustment to the conversion price of its convertible bonds ("Shu 22 Convertible Bonds") due to the dividend distribution, changing from 37.11 yuan to 36.84 yuan per share [19][21] - The adjustment will take effect on June 6, 2025, with the bonds being suspended from conversion from May 28 to June 5, 2025 [21]

Group 1 - The company will suspend the conversion of its convertible bonds "寿 22 转债" from May 28, 2025, until the equity distribution registration date due to the implementation of the 2024 profit distribution plan [1][2] - The profit distribution plan proposes a cash dividend of 2.70 yuan (including tax) for every 10 shares based on the total share capital on the equity distribution registration date [1][2] - The company will announce the implementation of the equity distribution and the adjustment of the conversion price for "寿 22 转债" on May 29, 2025 [2] Group 2 - Holders of "寿 22 转债" can convert their bonds until May 27, 2025, to enjoy the equity distribution benefits [2] - The company will adjust the conversion price of "寿 22 转债" in accordance with the terms outlined in the bond issuance prospectus after the equity distribution [2] - The company has provided contact information for inquiries regarding the announcement [2]